June 5, 2009

In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High

Bookmark and Share Email this story Print this post Add your comments

On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.

At 76 and 75, respectively, AstraZeneca and Johnson & Johnson lead the first-ever review of the pharmaceutical sector by Climate Counts.

Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.

Climate Counts evaluates firms’ commitments in four areas:

  • whether they have measured their carbon footprint
  • if they reduced their impact on global warming
  • if they have supported or blocked climate legislation or policy
  • to what level they have publicly disclosed their climate actions

AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.

Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.

Bookmark and Share Email this story Print this post Add your comments

Advertisers

Join the Discussion

Get EL Daily in your inbox, subscribe to free newsletter

Recent Daily News [ see all ]

  • 11/06/2009
  • 11/05/2009
  • 11/04/2009

Industry Voices [ see all ]

Greening the Automotive Supply Chain

Greening the Automotive Supply Chain

A Roadmap for a Renewable Energy Partnership

A Roadmap for a Renewable Energy Partnership

Forest Carbon Core to Climate Change Deal

Forest Carbon Core to Climate Change Deal

ARPA-E Deserves Support

ARPA-E Deserves Support

VCS and CarbonFix Tops in Review of Forestry Carbon Standards

VCS and CarbonFix Tops in Review of Forestry Carbon Standards